Angelika Dienel

1.8k total citations
39 papers, 1.2k citations indexed

About

Angelika Dienel is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Complementary and alternative medicine. According to data from OpenAlex, Angelika Dienel has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Experimental and Cognitive Psychology and 10 papers in Complementary and alternative medicine. Recurrent topics in Angelika Dienel's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers), Treatment of Major Depression (10 papers) and Natural Compound Pharmacology Studies (9 papers). Angelika Dienel is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers), Treatment of Major Depression (10 papers) and Natural Compound Pharmacology Studies (9 papers). Angelika Dienel collaborates with scholars based in Germany, Austria and United States. Angelika Dienel's co-authors include Siegfried Kasper, Hans‐Peter Volz, Meinhard Kieser, Sandra Schläfke, Wernér E.G. Müller, Hans‐Jürgen Möller, Markus Gastpar, Armin Szegedi, Ralf Kohnen and Ion Anghelescu and has published in prestigious journals such as Journal of Affective Disorders, Psychopharmacology and Clinical Neurophysiology.

In The Last Decade

Angelika Dienel

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angelika Dienel Germany	19	423	274	264	238	211	39	1.2k
Toshihiko Hanawa Japan	22	347 0.8×	142 0.5×	80 0.3×	305 1.3×	68 0.3×	133	1.5k
Jonathon L. Reay United Kingdom	17	296 0.7×	98 0.4×	56 0.2×	222 0.9×	66 0.3×	29	1.6k
Adejoke Y. Onaolapo Nigeria	23	149 0.4×	164 0.6×	54 0.2×	149 0.6×	81 0.4×	89	1.6k
Olakunle J. Onaolapo Nigeria	23	151 0.4×	161 0.6×	54 0.2×	150 0.6×	76 0.4×	89	1.6k
Michael Nöldner Germany	20	377 0.9×	396 1.4×	27 0.1×	241 1.0×	81 0.4×	46	1.3k
Irene Soeller United States	12	214 0.5×	120 0.4×	75 0.3×	120 0.5×	30 0.1×	12	633
Sophia Khom Austria	23	223 0.5×	131 0.5×	57 0.2×	154 0.6×	35 0.2×	44	1.4k
Camilla Day United Kingdom	7	209 0.5×	74 0.3×	77 0.3×	228 1.0×	76 0.4×	7	2.4k
Pramod Kumari Mediratta India	26	433 1.0×	316 1.2×	41 0.2×	174 0.7×	20 0.1×	81	1.8k
Juan Francisco Rodríguez‐Landa Mexico	21	189 0.4×	321 1.2×	31 0.1×	212 0.9×	56 0.3×	103	1.6k

Countries citing papers authored by Angelika Dienel

Since Specialization

Citations

This map shows the geographic impact of Angelika Dienel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika Dienel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika Dienel more than expected).

Fields of papers citing papers by Angelika Dienel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelika Dienel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika Dienel. The network helps show where Angelika Dienel may publish in the future.

Co-authorship network of co-authors of Angelika Dienel

This figure shows the co-authorship network connecting the top 25 collaborators of Angelika Dienel. A scholar is included among the top collaborators of Angelika Dienel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelika Dienel. Angelika Dienel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoerr, Robert, et al.. (2022). Single and Repeated Doses of EGb 761® do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects. Frontiers in Pharmacology. 13. 868843–868843. 3 indexed citations

Möller, Hans‐Jürgen, Hans‐Peter Volz, Angelika Dienel, Sandra Schläfke, & Siegfried Kasper. (2017). Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials. European Archives of Psychiatry and Clinical Neuroscience. 269(2). 183–193. 35 indexed citations

Gastpar, Markus, Wernér E.G. Müller, Hans‐Peter Volz, et al.. (2017). Silexan does not cause withdrawal symptoms even when abruptly discontinued. International Journal of Psychiatry in Clinical Practice. 21(3). 177–180. 13 indexed citations

Kasper, Siegfried, Wernér E.G. Müller, Hans‐Peter Volz, et al.. (2017). Silexan in anxiety disorders: Clinical data and pharmacological background. The World Journal of Biological Psychiatry. 19(6). 412–420. 44 indexed citations

Kasper, Siegfried, Ion Anghelescu, & Angelika Dienel. (2015). Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep – A randomized, placebo-controlled trial. European Neuropsychopharmacology. 25(11). 1960–1967. 66 indexed citations

Doroshyenko, Oxana, et al.. (2013). Drug Cocktail Interaction Study on the Effect of the Orally Administered Lavender Oil Preparation Silexan on Cytochrome P450 Enzymes in Healthy Volunteers. Drug Metabolism and Disposition. 41(5). 987–993. 45 indexed citations

Uehleke, Bernhard, et al.. (2012). Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder. Phytomedicine. 19(8-9). 665–671. 29 indexed citations

Dienel, Angelika, et al.. (2011). Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. European Journal of Clinical Pharmacology. 68(5). 553–560. 66 indexed citations

Kasper, Siegfried, Markus Gastpar, Wernér E.G. Müller, et al.. (2010). Better tolerability of St. Johnʼs wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression. International Clinical Psychopharmacology. 25(4). 204–213. 40 indexed citations

10.

Kasper, Siegfried, Markus Gastpar, Wernér E.G. Müller, et al.. (2010). Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial. International Clinical Psychopharmacology. 25(5). 277–287. 123 indexed citations

11.

Kasper, Siegfried, Hans‐Peter Volz, H.‐J. Möller, Angelika Dienel, & Meinhard Kieser. (2008). Continuation and long-term maintenance treatment with Hypericum extract WS® 5570 after recovery from an acute episode of moderate depression — A double-blind, randomized, placebo controlled long-term trial. European Neuropsychopharmacology. 18(11). 803–813. 34 indexed citations

12.

Kasper, Siegfried, Markus Gastpar, Wernér E.G. Müller, et al.. (2007). Efficacy of St. John’s wort extract WS® 5570 in acute treatment of mild depression. European Archives of Psychiatry and Clinical Neuroscience. 258(1). 59–63. 29 indexed citations

13.

Stange, Rainer, et al.. (2007). Phase II study on the effects of lavender oil (Silexan) in patients with neurasthenia, post‐traumatic stress disorders or somatisation disorder. Focus on Alternative and Complementary Therapies. 12(s1). 46–46. 5 indexed citations

14.

Kasper, Siegfried, Ion‐George Anghelescu, Armin Szegedi, Angelika Dienel, & Meinhard Kieser. (2006). Superior efficacy of St John's wort extract WS®5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]. BMC Medicine. 4(1). 14–14. 71 indexed citations

15.

Szegedi, Armin, Ralf Kohnen, Angelika Dienel, & Meinhard Kieser. (2005). Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ. 330(7490). 503–503. 130 indexed citations

16.

Dienel, Angelika, et al.. (2004). Safety of Hypericum extract in mildly to moderately depressed outpatients. Journal of Affective Disorders. 82(2). 303–307. 18 indexed citations

17.

Kasper, Siegfried & Angelika Dienel. (2002). Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology. 164(3). 301–308. 34 indexed citations

18.

Dienel, Angelika, et al.. (2002). Ginkgoextrakt bei eingeschranktem Sehvermogen - Behandlung mit dem Spezialextrakt EGb 761R bei Beeintrachtigung aufgrund seniler trockener Makuladegeneration*. Wiener Medizinische Wochenschrift. 152(15-16). 423–426. 13 indexed citations

19.

Stefan, Hermann, Frank Kerling, Dong Zhou, et al.. (2001). Therapeutic intensive seizure analysis (TISA) in presurgical evaluation of Losigamone. Acta Neurologica Scandinavica. 104(4). 195–201. 12 indexed citations

20.

Laakmann, G., Angelika Dienel, & Meinhard Kieser. (1998). Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities. Phytomedicine. 5(6). 435–442. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact